European Archives - Page 553 of 899 - European Medical Journal

Continue
1 Mins
11th October 2018

Effect of Renin-Angiotensin System Blockade in the Prevention of Thoracic Aortic Aneurysm Progression

Data are limited on the efficacy of medical therapies for non-syndromic thoracic aortic aneurysms (TAA), with expression of disease-causing genes…
10 Mins
11th October 2018

Cardioprotective Approaches to the Management of Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Do We Need Increased Surveillance in Elderly Women on Trastuzumab?

Due to recent advances in antineoplastic treatment for breast cancer, cancer-related mortality has substantially decreased. However, several systemic…
1 Mins
11th October 2018

High Cardiovascular Risk is Associated with the Degree of Fibrosis in Nonalcoholic Liver Disease

Cardiovascular diseases remain the leading cause of death worldwide. Nonalcoholic fatty liver disease (NAFLD), encompassing steatosis, nonalcoholic…
7 Mins
11th October 2018

The Cardiomyopathy of Iron Deficiency Anaemia

Anaemia is a significant challenge in global health; it is characterised by lower than normal levels of red blood cells and haemoglobin per unit volume…
1 Mins
11th October 2018

Prognostic Role of Cardiac Power Index in Patients with Biopsy-Proven Inflammatory Cardiomyopathy

Most patients with acute myocarditis and mild cardiac involvement recover without long-term sequelae. However, those patients with advanced cardiac…
13 Mins
11th October 2018

Treatment of Chronic Chagasic Patients: Is Killing the Parasite the Only Option?

Chronic Chagasic cardiomyopathy (CCC) is one of the principal challenges for clinicians treating asymptomatic Chagasic patients. Only benznidazole (BZ)…
2 Mins
11th October 2018

Risk Stratification and Age-Adjusted D-Dimer Test: Are They Satisfactory in Acute Pulmonary Embolism?

Pulmonary embolism (PE) is associated with high morbidity and mortality and often has a nonspecific clinical presentation; thus, prognostic assessment…
10th October 2018

An interview with Giles Platford from Takeda

An interview with Giles Platford, President Europe & Canada, Takeda Pharmaceutical Company Limited at the eyeforpharma conference, Barcelona, 2018. Mr Platford discusses Takeda’s Patient-Trust-Reputation-Business decision-making model to ensure the patient is at the heart of everything and what it takes to successfully manage a team and inspire innovation, while striving for sustainable business growth.
4 Mins
10th October 2018

Quality of Life and Psychosocial Issue in Skin Disease

Awareness of the impact that skin diseases can have on a patients’ quality of life has improved markedly within the dermatology community in recent…
1 Mins
8th October 2018

First-of-its-Kind Topical Spray Proving Effective at Treating Atopic Dermatitis

Cyclatop, a 5% cyclosporine topical spray, may be poised to deliver a significant therapeutic improvement for atopic dermatitis patients. A new study by…